Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01626625
Other study ID # NONUNISTEM1
Secondary ID
Status Recruiting
Phase Phase 1
First received June 12, 2012
Last updated June 22, 2012
Start date April 2010
Est. completion date January 2016

Study information

Verified date June 2012
Source Indonesia University
Contact Phedy Phe, MD
Email phedy@yahoo.com
Is FDA regulated No
Health authority Indonesia: Cipto Mangunkusumo Hospital
Study type Interventional

Clinical Trial Summary

The investigators hypothesized that mesenchymal stem cells can be isolated from fracture site, iliac crest, and tibial crest, and can be expanded to be used in the management of nonunion fracture.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date January 2016
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- athropic nonunion fracture of the long bone

Exclusion Criteria:

- immunocompromise,

- active infection,

- pathological fracture,

- ongoing hormonal therapy

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
stem cells + hydroxy apatite
patient will be transplanted with stem cells and hydroxyapatite
Other:
autograft taken from iliac crest
patient will be transplanted with autograft

Locations

Country Name City State
Indonesia RSCM Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary healing of fracture radiological union 1 year No
Secondary VAS visual analogue scale 1 year No